Investor · Hayward, CA

Roger M. Perlmutter

Open Roger in the network graph →

Filings

17

SEC Form D

Connections

128

co-filers

Capital

$1.1B

across filings

Active

Jun 2020

to Feb 2025

Most-connected co-filers (128)

Leon M. Chen · Hayward, CA8 shared Dror M. Berman · Hayward, CA8 shared Adam Goulburn · NEW YORK, NY6 shared Lachy N. Groom · West Hollywood, CA5 shared Ilya Usorov · New York, NY5 shared Robert T. Goldstein · Baltimore, MD4 shared John R. Quinn · Baltimore, MD4 shared Bradford Minsley · Raleigh, NC4 shared Georgia Papathomas · Newark, NJ4 shared John Glaser · Newark, NJ4 shared Simon J. Cox · HONG KONG, Hong Kong4 shared Brian S. Doyle · Baltimore, MD4 shared Manasa Mantravadi · Indianapolis, IN4 shared Joshua Stone · McKinney, TX4 shared Nicholas Stageberg · Rochester, MN4 shared George T. Hollan · Southlake, TX4 shared Joe D. Davis · Southlake, TX4 shared Raymond Updyke · New York, NY4 shared Anthony N. Tucker · SANTA MONICA, CA4 shared Thomas Wisniewski · Newark, NJ4 shared Craig Limoli · Newark, NJ4 shared John Paul Patrizio · Newark, NJ4 shared James B. Tananbaum · SAN FRANCISCO, CA4 shared Trevor Woolfe · Vancouver, British Columbia, Canada4 shared

Recent filings (17)

Eikon Therapeutics, Inc.Feb 2025 · 21 co-filers$400.0M NGM Bio Holdings, Inc.Jul 2024 · 25 co-filers$122.0M NGM Bio Holdings, Inc.Jul 2024 · 25 co-filers$122.0M WellSheet Inc.Sep 2023 · 14 co-filers$2.4M Eikon Therapeutics, Inc.Jun 2023 · 35 co-filers$535.0M WellSheet Inc.Sep 2022 · 14 co-filers$2.0M Eikon Therapeutics, Inc.Jan 2022 · 20 co-filers$525.0M WellSheet Inc.Sep 2021 · 14 co-filers$2.7M Eikon Therapeutics, Inc.May 2021 · 14 co-filers$107.8M LGF SHALLOW WATERFALL, L.P.Sep 2020 · 5 co-filers$11.1M SAM & LACHY INVESTMENTS (H1), L.P.Jul 2020 · 5 co-filers$18.0M LGF AQUARIUM TELECAST, L.P.Jul 2020 · 4 co-filers$18.0M WellSheet Inc.Jun 2020 · 14 co-filers$4.3M LGF II, L.P.Jun 2020 · 4 co-filers$100.0M LGF SIMPLE TRAPEZE, L.P.Jun 2020 · 4 co-filers$6.0M Exonics Therapeutics, Inc.Nov 2018 · 11 co-filers$42.0M Exonics Therapeutics, Inc.Nov 2018 · 11 co-filers$42.0M Immune Design Corp.Jan 2013 · 17 co-filers$34.0M AMGEN INCMar 2011 · 41 co-filers$2.3B

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Roger in the interactive graph →